Article

Alcon grant aims to fight cataract blindness in Africa

A $50,000 grant from the Alcon Foundation to Mercy Ships is funding two 3-month fellowships in advanced cataract techniques for expatriate or national West African surgeons onboard the Africa Mercy, a hospital ship in Cotonou, Benin, West Africa.

Fort Worth, TX

-A $50,000 grant from the Alcon Foundation to Mercy Ships is funding two 3-month fellowships in advanced cataract techniques for expatriate or national West African surgeons onboard the Africa Mercy, a hospital ship in Cotonou, Benin, West Africa. The fellowships are designed to complement additional training done with community eye workers and local eye surgeons to help build capacity during the ship’s 10-month port visit.

Patients in Africa often develop more dense and severe cataracts due to the frequency of eye trauma, the intensity of the sun’s rays along the equator, nutritional issues, and lack of access to ophthalmic intervention, according to Glenn Strauss, MD, chief of ophthalmology service and senior vice president of strategic health care for Mercy Ships.

“We believe that teaching these techniques contributes to a sustainable solution to eye-care needs in Africa because they are suited to local patients,” said Strauss, who began training the first fellowship grantee from Gabon in April.

Alcon has partnered with Mercy Ships since the charity’s inception 30 years ago. Since 1997, the company has donated more than $5.6 million worth of equipment, supplies, and pharmaceuticals to support the organization’s efforts to address preventable blindness.

“Mercy Ships’ vision of training local ophthalmologists to serve the eye-care needs of their own communities will help create sustainable eye-care delivery in some of the most underserved regions of Africa,” said Sara Woodward, director of Alcon’s corporate humanitarian services.

During the hospital ship’s 10-month stay in the West African port, Mercy Ships surgeons expect to evaluate and treat 20,000 patients for basic eye disease and provide specialized surgery for 3,000 people blinded by cataracts.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.